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1. Introduction 
Several studies have shown that the carcinogen 
N-acetoxy-N-2-acetylaminofluorene (AAAF) reacts 
in vivo and in vitro with native DNA and that the 
DNA contains a major (80%) adduct N(deoxyguanosin- 
8-yl)-acetylaminofluorene (dGuo8-AAF) and a minor 
(20%) adduct 3{deoxyguanosin-N2-yl)-acetylamino- 
fluorene (dGuo-N2-AAF) (reviewed [1,2]). It has 
been shown that the major alteration induced by the 
fluorene ring is the creation of locally disorganized 
regions inside the double helical structure [3-81 . 
Methods sensitive enough to assay the regions of 
DNAmodified by a carcinogen at the levels of modifi- 
cation occuring in the ‘in vivo’ carcinogenesis experi- 
ments would be of great value. The immunological 
method has already been shown to be able to detect 
small modifications in DNA (see e.g. [9,10]). On the 
other hand, the study of the specificity of the anti- 
bodies can bring some knowledge on the conforma- 
tion of the antigen. For these reasons, we have under- 
taken a study of the immunogenicity of native DNA 
after reaction with AAAF. 
In this paper, we show that native DNA slightly 
modified by AAAF can induce in rabbits the synthesis 
of specific antibodies which selectively recognize 
AAF-substituted DNA. A methods of purification of 
these antibodies is described. Also, the association 
constants for the binding of the antibodies and 
several igands are reported. 
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2. Materials and methods 
Native calf thymus DNA (mol. wt cy 5 X 10’) and 
denatured samples were modified by the reaction 
with AAAF according to the procedure in [4] . The 
percentage of bound AAF were determined from the 
analysis of the ultraviolet spectra. We will write 
nDNA-AAF or dDNA-AAF for native or denatured 
DNA which has been reacted with AAAF and the 
percentage of modified bases will be given into 
brackets. No large denaturation of native DNA 
occured by the reaction with AAAF because the 
absorbances did not significantly change between 
20°C and a temperature (T, -2O’C). 
GMP-AAF was prepared according to the procedure 
in [6] . 
2 .l . Affinity column 
dDNA-AAF was linked to Sepharose 4B through a 
spacer, the 6-aminohexanoic acid. Activation of the 
Sepharose 4B and the reaction with 6-aminohexanoic 
acid, has been described [ 1 l] . dDNA-AAF was 
reacted with the 6-aminohexanoic acid, at pH 5, in 
presence of carbodiimide as already described for the 
linkage of oligo(A) or poly(A).poly(U) [ 11,121. 
About 0.4 mg dDNA-AAF (23%) were linked per ml 
wet Sepharose. 
Fab fragments were prepared by the reaction of 
the IgG with papain [ 131. They were purified on the 
Sepharose dDNA-AAF column. The elution of the 
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bound Fab fragments was done with 1 M acetic acid. tion and immunodiffusion against goat antisera anti- 
They were further purified by gel filtration on a IgG or anti-IgM. By gel diffusion these IgG were 
Sephadex G-200 column. Immunodiffusion in agarose found to react with nDNA-AAF and dDNA-AAF but 
and precipitin assays were performed as in [ 1 l] . not with nDNA or dDNA. 
Fluorescence measurements were performed with 
a spectrofluorimeter Farrand MKI [ 1 l] . 
All the IgG can be precipitated by dDNA-AAF as 
shown in fig.1. Moreover, the precipitation can be 
inhibited by GMP-AAF but not by GMP or AMP. 
2.2. Immunization 
Two random-bred rabbits were injected with a 
mixture of equal weights of nDNA-AAF (5%) and 
methylated bovine serum albumin according to the 
procedure in [ 141. The rabbits were bled a week 
after the intravenous booster. 
3. Results 
3 .l . Reactivity 
The reactivity of the antisera was first analyzed by 
double diffusion in agarose (1%). The antisera reacted 
with nDNA-AAF (5%), dDNA-AAF (23%), dDNA 
but not with nDNA. There was no more precipitation 
with dDNA in 0.5 M NaCl while nDNA-AAF and 
dDNA-AAF were still precipitated. 
3.2. Purification of the antibodies 
The antibodies were purified by affinity chromatog- 
raphy on a Sepharose-dDNA-AAF column. The 
serum was applied on the column equilibrated with 
0.15 M NaCl, 5 mM Tris-HCl, pH 7.5,0.1 mM EDTA 
(buffer 1). The column was washed with buffer 1 
until the effluent Ass,, was < 0.04, then with 0.5 M 
NaCl pH 7.5 and then with 1 mM acetic acid 
(2 column vol.). The antibodies were eluted with 2 M 
acetic acid. They were neutralized by dialysis against 
0.1 M Tris-HCl, pH 8, and then against buffer 1. 
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All the antibodies which react with nDNA-AAF 
were bound to the Sepharose-dDNA-AAF column. 
By immunodiffusion, no precipitation was found 
between the proteins which did not bind to the 
column and nDNA-AAF or dDNA-AAF. 
The eluted antibodies reacted with dDNA and 
with DNA-AAF. They were applied on a Sepharose 
dDNA column. About 15% of the proteins were 
bound to this column. The unbound proteins were 
further purified on a Sephadex G-200 column. 
Almost all the proteins were eluted in a single peak. 
These proteins are IgG as shown by ultracentrifuga- 
F&l.(A) Precipitation of DNA-AAF by the purified anti- 
bodies. Antibodies, 52 c(g, were mixed with nDNA-AAF 
(5.7%) (e-e) or with dDNA-AAF (23%) (+-+) (B) Inhibi- 
tion of DNA-AAF precipitation as a function of the 
logarithm of the inhibitor concentration. Inhibition of 
nDNA-AAF (5.7%) precipitation (0) and of dDNA-AAF 
(5.3%) precipitation (+) by GMP-AAF. Inhibition of nDNA- 
AAF (5.7%) precipitation by GMP (A) and by AMP (0). 
nDNA-AAF (5.7%) cont. 1.7 X 1 0e4 M and dDNA-AAF 
(5.3%) cont. 1.9 X lo-’ M (in nucleotide residues). Amount 
of antibodies, 52 r.tg in 120 ~1 solvent. The antibodies and the 
inhibitor were mixed and kept 1 h at 35°C and then DNA- 
AAF was added. After 24 h, the amounts of antibodies in 
the precipitate were determined. 
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3.3. Association constants 
Solutions of Fab fragments are fluorescent. In 
presence of GMP-AAF or DNA-AAF, the fluorescence 
is quenched (X,, = 295 nm, h, = 355 nm) and 
tends towards a limit for large amounts of ligand. 
Assuming the same quenching for all the bound Fab 
fragments, one can calculate r/c and r, where Y is the 
molar ratio bound GMP-AAP over Fab fragments and 
c the concentration of free GMP-AAF. The variation 
of r/c as a function of Y is shown in fig .2. The mean 
value of the association constant for the binding of 
Fab fragments to GMP-AAF is 2 X 1 O6 M-’ [ 15 ,161 . 
The association constant for the binding of Fab 
fragments to nDNA-AAF (5.6%) and to dDNA-AAF 
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Fig.2. Scatchard plot for the binding of GMP-AAF to Fab 
fragments. Solvent 50 mM NaCl, 5 mM Tris-HCl, 0.1 mM 
EDTA,pH 7.5,temp. lS”C.Fab fragmentsconc.4.8 X lo-’ M 
@exe = 290 nm, hem = 355 nm). 
(4.4%) were also determined, the concentration of 
DNA being expressed in mol modified nucleotide 
residues. It was assumed that all the modified bases 
were equivalent and sufficiently far apart so that two 
modified bases were not covered by one Fab fragment. 
This assumption is justified because in the precipitin 
assays, in the region of antibodies excess, the molar 
ratio modified nucleotide residues over IgG in the 
precipitate is - 2 for nDNA-AAF (5.7%) (see fig.l) 
and for dDNA-AAF (4.4%) (results not shown). The 
association constants for the binding of Fab fragments 
to nDNA-AAF or dDNA-AAF are the same (4 X lo6 
M-l ) within the experimental error. 
4. Discussion 
These results show that injections in rabbits of 
native DNA slightly modified by the reaction with 
AAAF can induce the synthesis of antibodies which 
react with the modified DNA. The antibodies have 
been purified by affinity chromatography on a 
Sephadex-dDNA-AAF column. It is possible that 
some specific antibodies to nDNA-AAF were lost. 
In the limit of sensitivity of double diffusion, all the 
antibodies to nDNA-AAF were bound to the Sepharose 
dDNA-AAF column. After passage on a Sepharose- 
dDNA column, the antibodies only react with 
DNA-AAF. 
The purified antibodies do not precipitate DNA. 
The precipitation of DNA-AAF can be inhibited by 
GMP-AAF and almost not by GMP. Thus guanosine 
residues or oligonucleotides are not the immuno- 
determinant group while AAF is involved. On the 
other hand, the association constants for the binding 
of the Fab fragments to GMP-AAF, dDNA-AAF and 
nDNA-AAF are of the same order of magnitude. 
These results imply that the accessibility of the anti- 
genie determinant (dGMP-AAF residues) is the same 
in single stranded and double stranded conformations. 
In conclusion, it is shown that highly purified 
antibodies to DNA-AAF can be obtained. These anti- 
bodies react with nDNA-AAF. Therefore they can be 
used as probes to detect AAF linked to DNA without 
having to degrade the modified DNA. This is interest- 
ing as compared to the antibodies to guanosine-AAF. 
It has been recently found that they react poorly 
with nDNA-AAF [17] . Finally, since the antibodies 
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have the same affinity to GMP-AAF, nDNA-AAF and 
dDNA-AAF, this shows that if the AAF-residues lie 
inside the DNA structure [2,4,8] , they must be 
sufficiently free to be as reactive as free GMP-AAF. 
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